The Effect of Early Intervention With Sumatriptan Tablets on Migraine-Associated Productivity Loss
| Autor: | Frederick R. Taylor, James U. Adelman, W. Jacqueline Kwong |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Migraine Disorders Pain Occupational medicine Intervention (counseling) Task Performance and Analysis medicine Humans Productivity Retrospective Studies Clinical Trials as Topic Sumatriptan business.industry Public Health Environmental and Occupational Health medicine.disease Serotonin Receptor Agonists Migraine Physical therapy Female business After treatment medicine.drug |
| Zdroj: | Journal of Occupational and Environmental Medicine. 47:1167-1173 |
| ISSN: | 1076-2752 |
| DOI: | 10.1097/01.jom.0000174296.46911.79 |
| Popis: | Impaired performance, which can considerably impact employee output, occurs when employees attempt to continue work with inadequate treatment while experiencing a migraine episode. This analysis examined productivity loss as a result of migraine after treatment with sumatriptan tablets and patients' usual non-triptan therapy when pain was mild (early intervention) versus when pain was moderate/severe.The authors conducted a retrospective analysis of data on 6803 migraine days reported by 251 subjects who participated in a clinical trial.Although early intervention significantly reduced productivity loss compared with treatment when pain was moderate/severe for both sumatriptan and non-triptan therapy, productivity loss was consistently lower for sumatriptan than non-triptan therapy for all predose pain intensity levels.These findings suggest that the pharmaco-economic benefits of early intervention with sumatriptan tablets, like the clinical benefits, exceed those of delayed intervention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|